Dr. Arelis Madera, MD
NPI: 1487697272
Total Payments
$2.2M
2024 Payments
$228,447
Companies
64
Transactions
4,101
Medicare Patients
12,878
Medicare Billing
$936,778
Payment Breakdown by Category
Other$1.7M (76.9%)
Travel$361,649 (16.8%)
Food & Beverage$72,202 (3.4%)
Consulting$62,780 (2.9%)
Education$491.70 (0.0%)
Research$125.00 (0.0%)
Gifts$118.80 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.5M | 1,145 | 71.8% |
| Travel and Lodging | $361,649 | 641 | 16.8% |
| Food and Beverage | $72,202 | 2,187 | 3.4% |
| Consulting Fee | $62,780 | 27 | 2.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $57,902 | 26 | 2.7% |
| Honoraria | $30,159 | 16 | 1.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $22,650 | 18 | 1.1% |
| Education | $491.70 | 38 | 0.0% |
| Unspecified | $125.00 | 1 | 0.0% |
| Gift | $118.80 | 2 | 0.0% |
Payments by Type
General
$2.2M
4,100 transactions
Research
$125.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $728,575 | 1,261 | $0 (2024) |
| Novo Nordisk Inc | $513,468 | 582 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $194,050 | 222 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $173,251 | 293 | $0 (2024) |
| Dexcom, Inc. | $127,072 | 154 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $92,951 | 168 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $65,948 | 233 | $0 (2020) |
| Abbott Laboratories | $62,541 | 127 | $0 (2024) |
| Radius Health, Inc. | $42,896 | 120 | $0 (2024) |
| Amgen Inc. | $31,540 | 93 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $228,447 | 409 | Lilly USA, LLC ($103,619) |
| 2023 | $209,803 | 411 | Lilly USA, LLC ($84,006) |
| 2022 | $281,589 | 509 | Lilly USA, LLC ($94,335) |
| 2021 | $240,865 | 388 | Novo Nordisk Inc ($76,852) |
| 2020 | $171,840 | 356 | Lilly USA, LLC ($92,656) |
| 2019 | $316,418 | 683 | Lilly USA, LLC ($102,546) |
| 2018 | $335,843 | 699 | Lilly USA, LLC ($103,163) |
| 2017 | $368,376 | 646 | Lilly USA, LLC ($93,884) |
All Payment Transactions
4,101 individual payment records from CMS Open Payments — Page 1 of 165
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Endocrinology | ||||||
| 12/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $557.00 | General |
| Category: Cardio-renal | ||||||
| 12/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $123.48 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,621.00 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: LIVER DISEASE | ||||||
| 12/10/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $102.30 | General |
| Category: Diabetes Care | ||||||
| 12/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Travel and Lodging | In-kind items and services | $1,325.25 | General |
| Category: Cardio-renal | ||||||
| 12/06/2024 | Kyowa Kirin, Inc. | — | Food and Beverage | In-kind items and services | $62.89 | General |
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $141.52 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $6.43 | General |
| Category: Diabetes Care | ||||||
| 12/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $112.42 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 11/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Cardiology | ||||||
| 11/22/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,298.00 | General |
| Category: Endocrinology | ||||||
| 11/22/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Almatica Pharma LLC | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: OSTEOPOROSIS | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $975.00 | General |
| Category: Diabetes Care | ||||||
| 11/19/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: Automated insulin delivery system | ||||||
| 11/18/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | Cash or cash equivalent | $41.02 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 3,236 | 5,191 | $733,867 | $261,112 |
| 2022 | 27 | 3,193 | 5,381 | $736,152 | $257,087 |
| 2021 | 30 | 3,398 | 5,283 | $657,770 | $240,153 |
| 2020 | 25 | 3,051 | 4,405 | $496,911 | $178,426 |
Total Patients
12,878
Total Services
20,260
Medicare Billing
$936,778
Procedure Codes
110
All Medicare Procedures & Services
110 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 746 | 1,566 | $414,007 | $143,401 | 34.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 517 | 1,309 | $93,316 | $34,034 | 36.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 128 | 128 | $58,707 | $20,456 | 34.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 107 | 113 | $41,871 | $14,483 | 34.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 98 | 98 | $34,024 | $11,975 | 35.2% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 79 | 80 | $23,656 | $8,580 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 80 | $14,953 | $5,198 | 34.8% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2023 | 69 | 81 | $10,161 | $3,680 | 36.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 220 | 284 | $4,845 | $2,381 | 49.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 108 | 125 | $4,200 | $2,058 | 49.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 155 | 177 | $3,738 | $1,832 | 49.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,694 | $1,640 | 34.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 109 | 117 | $3,133 | $1,535 | 49.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 130 | 153 | $2,971 | $1,457 | 49.0% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 11 | 11 | $3,136 | $1,063 | 33.9% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 99 | 117 | $2,111 | $1,034 | 49.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 18 | 18 | $2,368 | $874.44 | 36.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 26 | 27 | $1,598 | $783.27 | 49.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 159 | 219 | $1,437 | $702.99 | 48.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 111 | 120 | $1,387 | $679.20 | 49.0% |
| 82533 | Cortisol (hormone) measurement, total | Office | 2023 | 29 | 41 | $1,337 | $654.77 | 49.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 15 | $1,757 | $614.32 | 35.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 111 | 120 | $1,243 | $609.60 | 49.0% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 18 | 90 | $1,489 | $596.00 | 40.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 34 | 35 | $1,056 | $517.30 | 49.0% |
About Dr. Arelis Madera, MD
Dr. Arelis Madera, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Port Charlotte, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487697272.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arelis Madera, MD has received a total of $2.2M in payments from pharmaceutical and medical device companies, with $228,447 received in 2024. These payments were reported across 4,101 transactions from 64 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.5M).
As a Medicare-enrolled provider, Madera has provided services to 12,878 Medicare beneficiaries, totaling 20,260 services with total Medicare billing of $936,778. Data is available for 4 years (2020–2023), covering 110 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Port Charlotte, FL
- Active Since 06/13/2006
- Last Updated 02/06/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1487697272
Products in Payments
- TRULICITY (Drug) $391,933
- MOUNJARO (Drug) $212,019
- Kerendia (Drug) $194,034
- Ozempic (Drug) $147,504
- Tresiba (Drug) $101,279
- FARXIGA (Drug) $92,370
- RYBELSUS (Drug) $90,158
- SOLIQUA (Drug) $82,990
- Rybelsus (Drug) $69,090
- INVOKANA (Drug) $65,747
- DEXCOM G7 GSS (161) (Medical Supply) $63,380
- TOUJEO (Drug) $53,681
- Victoza (Drug) $48,376
- Tymlos (Biological) $42,689
- FreeStyle Libre Pro (Device) $35,700
- DEXCOM G6 TRANSMITTER (Device) $34,833
- Repatha (Biological) $31,019
- GVOKE PFS (Drug) $23,476
- FREESTYLE LIBRE 3 (Device) $21,542
- JARDIANCE (Drug) $18,547
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Port Charlotte
Lenita Hanson, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $120,747
Endocrinology, Diabetes & Metabolism $120,747
Steven Halasz, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,891
Endocrinology, Diabetes & Metabolism $1,891
Dr. Numa Tamayo, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,179
Endocrinology, Diabetes & Metabolism $1,179
Alexa Fausey
Endocrinology, Diabetes & Metabolism — Payments: $507.66
Endocrinology, Diabetes & Metabolism $507.66
Dr. Adelina Flores, M.d, M.D
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism
Teresita De Lara, M.d, M.D
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism